222 related articles for article (PubMed ID: 17526933)
1. Polyunsaturated fat in the methionine-choline-deficient diet influences hepatic inflammation but not hepatocellular injury.
Lee GS; Yan JS; Ng RK; Kakar S; Maher JJ
J Lipid Res; 2007 Aug; 48(8):1885-96. PubMed ID: 17526933
[TBL] [Abstract][Full Text] [Related]
2. Dietary sucrose is essential to the development of liver injury in the methionine-choline-deficient model of steatohepatitis.
Pickens MK; Yan JS; Ng RK; Ogata H; Grenert JP; Beysen C; Turner SM; Maher JJ
J Lipid Res; 2009 Oct; 50(10):2072-82. PubMed ID: 19295183
[TBL] [Abstract][Full Text] [Related]
3. Differential hepatotoxicity of dietary and DNL-derived palmitate in the methionine-choline-deficient model of steatohepatitis.
Pierce AA; Pickens MK; Siao K; Grenert JP; Maher JJ
BMC Gastroenterol; 2015 Jun; 15():72. PubMed ID: 26103964
[TBL] [Abstract][Full Text] [Related]
4. Dietary fructose exacerbates hepatocellular injury when incorporated into a methionine-choline-deficient diet.
Pickens MK; Ogata H; Soon RK; Grenert JP; Maher JJ
Liver Int; 2010 Sep; 30(8):1229-39. PubMed ID: 20536716
[TBL] [Abstract][Full Text] [Related]
5. Blockade of interleukin-6 signaling enhances hepatic steatosis but improves liver injury in methionine choline-deficient diet-fed mice.
Yamaguchi K; Itoh Y; Yokomizo C; Nishimura T; Niimi T; Fujii H; Okanoue T; Yoshikawa T
Lab Invest; 2010 Aug; 90(8):1169-78. PubMed ID: 20368703
[TBL] [Abstract][Full Text] [Related]
6. Monocyte chemoattractant protein-1 deficiency does not affect steatosis or inflammation in livers of mice fed a methionine-choline-deficient diet.
Kassel KM; Guo GL; Tawfik O; Luyendyk JP
Lab Invest; 2010 Dec; 90(12):1794-804. PubMed ID: 20697377
[TBL] [Abstract][Full Text] [Related]
7. MCD-induced steatohepatitis is associated with hepatic adiponectin resistance and adipogenic transformation of hepatocytes.
Larter CZ; Yeh MM; Williams J; Bell-Anderson KS; Farrell GC
J Hepatol; 2008 Sep; 49(3):407-16. PubMed ID: 18534710
[TBL] [Abstract][Full Text] [Related]
8. Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation.
Larter CZ; Yeh MM; Cheng J; Williams J; Brown S; dela Pena A; Bell-Anderson KS; Farrell GC
J Gastroenterol Hepatol; 2008 Feb; 23(2):267-75. PubMed ID: 17868330
[TBL] [Abstract][Full Text] [Related]
9. Sitagliptin attenuates methionine/choline-deficient diet-induced steatohepatitis.
Jung YA; Choi YK; Jung GS; Seo HY; Kim HS; Jang BK; Kim JG; Lee IK; Kim MK; Park KG
Diabetes Res Clin Pract; 2014 Jul; 105(1):47-57. PubMed ID: 24842243
[TBL] [Abstract][Full Text] [Related]
10. Stress signaling in the methionine-choline-deficient model of murine fatty liver disease.
Soon RK; Yan JS; Grenert JP; Maher JJ
Gastroenterology; 2010 Nov; 139(5):1730-9, 1739.e1. PubMed ID: 20682321
[TBL] [Abstract][Full Text] [Related]
11. Pentoxifylline attenuates steatohepatitis induced by the methionine choline deficient diet.
Koppe SW; Sahai A; Malladi P; Whitington PF; Green RM
J Hepatol; 2004 Oct; 41(4):592-8. PubMed ID: 15464239
[TBL] [Abstract][Full Text] [Related]
12. Rodent nutritional model of steatohepatitis: effects of endotoxin (lipopolysaccharide) and tumor necrosis factor alpha deficiency.
Kirsch R; Clarkson V; Verdonk RC; Marais AD; Shephard EG; Ryffel B; de la M Hall P
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):174-82. PubMed ID: 16706830
[TBL] [Abstract][Full Text] [Related]
13. The pathogenesis of ethanol versus methionine and choline deficient diet-induced liver injury.
Gyamfi MA; Damjanov I; French S; Wan YJ
Biochem Pharmacol; 2008 Feb; 75(4):981-95. PubMed ID: 18036573
[TBL] [Abstract][Full Text] [Related]
14. n-3 polyunsaturated fatty acids worsen inflammation and fibrosis in experimental nonalcoholic steatohepatitis.
Provenzano A; Milani S; Vizzutti F; Delogu W; Navari N; Novo E; Maggiora M; Maurino V; Laffi G; Parola M; Marra F
Liver Int; 2014 Jul; 34(6):918-30. PubMed ID: 24628836
[TBL] [Abstract][Full Text] [Related]
15. Rodent nutritional model of non-alcoholic steatohepatitis: species, strain and sex difference studies.
Kirsch R; Clarkson V; Shephard EG; Marais DA; Jaffer MA; Woodburne VE; Kirsch RE; Hall Pde L
J Gastroenterol Hepatol; 2003 Nov; 18(11):1272-82. PubMed ID: 14535984
[TBL] [Abstract][Full Text] [Related]
16. Enhanced expression of Nrf2 in mice attenuates the fatty liver produced by a methionine- and choline-deficient diet.
Zhang YK; Yeager RL; Tanaka Y; Klaassen CD
Toxicol Appl Pharmacol; 2010 Jun; 245(3):326-34. PubMed ID: 20350562
[TBL] [Abstract][Full Text] [Related]
17. Central role of PPARalpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice.
Ip E; Farrell GC; Robertson G; Hall P; Kirsch R; Leclercq I
Hepatology; 2003 Jul; 38(1):123-32. PubMed ID: 12829994
[TBL] [Abstract][Full Text] [Related]
18. Visfatin exacerbates hepatic inflammation and fibrosis in a methionine-choline-deficient diet mouse model.
Heo YJ; Choi SE; Lee N; Jeon JY; Han SJ; Kim DJ; Kang Y; Lee KW; Kim HJ
J Gastroenterol Hepatol; 2021 Sep; 36(9):2592-2600. PubMed ID: 33600604
[TBL] [Abstract][Full Text] [Related]
19. Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice.
McCuskey RS; Ito Y; Robertson GR; McCuskey MK; Perry M; Farrell GC
Hepatology; 2004 Aug; 40(2):386-93. PubMed ID: 15368443
[TBL] [Abstract][Full Text] [Related]
20. Alpha-lipoic acid attenuates methionine choline deficient diet-induced steatohepatitis in C57BL/6 mice.
Min AK; Kim MK; Kim HS; Seo HY; Lee KU; Kim JG; Park KG; Lee IK
Life Sci; 2012 Jan; 90(5-6):200-5. PubMed ID: 22154902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]